Status:
NOT_YET_RECRUITING
Physical Exercise to Prevent Mild-cognitive Impairment in Patients With Kidney Disfunctions
Lead Sponsor:
Biogem s.c.ar.l.
Conditions:
Chronic Kidney Disease (Stages 4 and 5)
Mild Cognitive Impairment (MCI)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research project focuses on improving memory and thinking (cognitive function) in people with advanced chronic kidney disease (CKD), a condition that affects about 10% of adults and is often link...
Detailed Description
The project aims to test the impact of exercise programs on cognitive function in stage G 4-5 CKD and dialysis patients with MCI in a randomised clinical trial. A structured physical exercise program ...
Eligibility Criteria
Inclusion
- CKD at KDOQI stage 4-5
- concomitant MCI (MOCA - MMSE (17 \< MoCA \< 26) or (16 \< MMSE \< 24)
Exclusion
- Absolute contraindication to exercise training (e.g. unstable angina, major amputation, severe heart failure, etc.)
- Known life expectancy \< 6-month
- Uncorrected anemia (Hb \<9 g/dl)
- Non-provision of informed consent
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2030
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT07160959
Start Date
January 1 2026
End Date
April 30 2030
Last Update
September 8 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique - Hôpitaux de Paris (AP-HP), Division of Geriatry
Paris, France
2
Biogem
Ariano Irpino, Italy, 83031
3
Lithuanian University of Health Sciences
Kaunas, Lithuania
4
University Medical Center Groningen, Department of Nephrology
Groningen, Netherlands